title: Consensus recommendations for standard therapy of glomerular disease in dogs.
abstract: Standard therapy forms the basic foundation for care of dogs with glomerular disease, as it is herein recommended for use in all affected animals regardless of causation of the disease. Consensus recommendations target the evaluation and management of proteinuria, inhibition of the renin-angiotensin-aldosterone system, modification in dietary intake with special consideration for those nutrients with renal effects, diagnosis and treatment of systemic hypertension, and evaluation and management of body fluid volume status in dogs with glomerular disease.
authors.forename: S
authors.initials: S
authors.lastname: Brown
authors.forename: J
authors.initials: J
authors.lastname: Elliott
authors.forename: T
authors.initials: T
authors.lastname: Francey
authors.forename: D
authors.initials: D
authors.lastname: Polzin
authors.forename: S
authors.initials: S
authors.lastname: Vaden
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy* / Q000473:pathology; D004285:Dogs; D005921:Glomerulonephritis / Q000188:drug therapy / Q000473:pathology / Q000662:veterinary*; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D012084:Renin-Angiotensin System
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D000451:Mineralocorticoid Receptor Antagonists
keywords: Amyloidosis; Chronic renal failure; Glomerulonephritis; Protein losing nephropathy